{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:57:42Z","timestamp":1768827462164,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"crossref","award":["104-2628-M-019-001-MY3"],"award-info":[{"award-number":["104-2628-M-019-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"crossref","award":["103-2627-M-007-002-MY3"],"award-info":[{"award-number":["103-2627-M-007-002-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"crossref","award":["102-2113-M-019-001-MY3"],"award-info":[{"award-number":["102-2113-M-019-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jconrel.2015.11.028","type":"journal-article","created":{"date-parts":[[2015,11,28]],"date-time":"2015-11-28T12:32:32Z","timestamp":1448713952000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Gold nanoparticles modified with self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant"],"prefix":"10.1016","volume":"221","author":[{"given":"San-Shan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Tsung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Jia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.11.028_bb0005","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1213\/ane.0b013e31819bcc9c","article-title":"Blood coagulation: hemostasis and thrombin regulation","volume":"108","author":"Tanaka","year":"2009","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000136","article-title":"An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes","volume":"2","author":"Cove","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.rcl.2013.08.003","article-title":"New insights in thromboembolic disease","volume":"52","author":"Remy-Jardin","year":"2014","journal-title":"Radiol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0020","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1538-7836.2007.02446.x","article-title":"The intrinsic pathway of coagulation: a target for treating thromboembolic disease","volume":"5","author":"Gailani","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40138-013-0014-6","article-title":"Anticoagulants: a review of the pharmacology, dosing, and complications","volume":"1","author":"Alquwaizani","year":"2013","journal-title":"Curr. Emerg. Hosp. Med. Rep."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.thromres.2011.10.017","article-title":"Thrombin generation in clinical conditions","volume":"129","author":"ten Cate","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0035","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.2011.03916.x","article-title":"Direct thrombin inhibitors","volume":"72","author":"Lee","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1378\/chest.14-2028","article-title":"The association of direct thrombin inhibitor anticoagulants with cardiac thromboses","volume":"147","author":"Davidson","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0050","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjmed.2011.06.009","article-title":"Anticoagulation-associated adverse drug events","volume":"124","author":"Piazza","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0055","doi-asserted-by":"crossref","first-page":"g7566","DOI":"10.1136\/bmj.g7566","article-title":"Heparin induced thrombocytopenia","volume":"350","author":"Linkins","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203309353171","article-title":"Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity?","volume":"19","author":"Lefkou","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0065","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.3390\/ijms13033341","article-title":"Generating aptamers by cell-SELEX for applications in molecular medicine","volume":"13","author":"Ye","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0070","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.chembiol.2014.08.003","article-title":"Aptamers and SELEX in chemistry & biology","volume":"21","author":"Famulok","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0075","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.2174\/092986711797189556","article-title":"Nucleic acid aptamers against proteases","volume":"18","author":"Dupont","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/355564a0","article-title":"Selection of single-stranded DNA molecules that bind and inhibit human thrombin","volume":"355","author":"Bock","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0085","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1006\/jmbi.1997.1275","article-title":"Oligonucleotide inhibitors of human thrombin that bind distinct epitopes","volume":"272","author":"Tasset","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0090","doi-asserted-by":"crossref","first-page":"17651","DOI":"10.1016\/S0021-9258(17)46749-4","article-title":"The structure of alpha-thrombin inhibited by a 15-mer single-stranded dna aptamer","volume":"268","author":"Padmanabhan","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0095","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2008.03162.x","article-title":"Anticoagulant characteristics of hd1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase","volume":"6","author":"M\u00fcller","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.nano.2011.08.011","article-title":"Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures","volume":"8","author":"Rangnekar","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/asia.200900421","article-title":"Engineering dendritic aptamer assemblies as superior inhibitors of protein function","volume":"5","author":"Kim","year":"2010","journal-title":"Chem. Asian. J."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2012.07.011","article-title":"Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer","volume":"136","author":"Musumeci","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0115","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2174\/138161212799958387","article-title":"Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications","volume":"18","author":"Avi\u00f1\u00f3","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0120","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/adfm.201000642","article-title":"Aptamer-conjugated nanoparticles efficiently control the activity of thrombin","volume":"20","author":"Shiang","year":"2010","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0125","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1021\/ac502440h","article-title":"Kinetic adsorption profile and conformation evolution at the DNA-gold nanoparticle interface probed by dynamic light scattering","volume":"86","author":"Wang","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0130","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1021\/ja304118z","article-title":"Designed diblock oligonucleotide for the synthesis of spatially isolated and highly hybridizable functionalization of DNA-gold nanoparticle nanoconjugates","volume":"134","author":"Pei","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0135","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.bios.2010.01.005","article-title":"Label-free colorimetric detection of picomolar thrombin in blood plasma using a gold nanoparticle-based assay","volume":"25","author":"Chen","year":"2010","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0140","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.1021\/nn501129q","article-title":"Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade","volume":"8","author":"Lin","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcis.2013.08.043","article-title":"Fast assembly of non-thiolated DNA on gold surface at lower pH","volume":"411","author":"Jiang","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/am.2014.131","article-title":"Clicking DNA to gold nanoparticles: poly-adenine-mediated formation of monovalent DNA-gold nanoparticle conjugates with nearly quantitative yield","volume":"7","author":"Yao","year":"2015","journal-title":"NPG Asia Mater."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0155","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1021\/jp711869p","article-title":"Nucleotide-surface interactions in DNA modified Au nanoparticle conjugates: sequence effects on reactivity and hybridization","volume":"112","author":"Katherine","year":"2008","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0160","doi-asserted-by":"crossref","first-page":"11777","DOI":"10.1093\/nar\/gks899","article-title":"Selection is more intelligent than design: improving the affinity of a bivalent ligand through directed evolution","volume":"40","author":"Ahmad","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0165","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1002\/ange.201101718","article-title":"Gold nanoparticles presenting hybridized self-assembled aptamers that exhibit enhanced inhibition of thrombin","volume":"123","author":"Shiang","year":"2011","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0170","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1039\/C1RA00344E","article-title":"Highly flexible and stable aptamer-caged nanoparticles for control of thrombin activity","volume":"2","author":"Hsu","year":"2012","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0175","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/bi801630b","article-title":"Bivalent ligands with long nanometer-scale flexible linkers","volume":"48","author":"Tian","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-62703-339-8_10","article-title":"Thrombin clotting time","volume":"992","author":"Ignjatovic","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1160\/TH07-11-0693","article-title":"The direct thrombin inhibitor hirudin","volume":"99","author":"Greinacher","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20060656","article-title":"Conformational transitions induced in heparin octasaccharides by binding with antithrombin III","volume":"399","author":"Guerrini","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0195","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1586\/ehm.10.53","article-title":"Pharmacology of argatroban","volume":"3","author":"Jeske","year":"2010","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tcm.2014.09.001","article-title":"Warfarin pharmacogenetics","volume":"25","author":"Johnson","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/nl802958f","article-title":"Polyvalent DNA nanoparticle conjugates stabilize nucleic acids","volume":"9","author":"Seferos","year":"2009","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nantod.2014.12.003","article-title":"RES blockade: a strategy for boosting efficiency of nanoparticle drug","volume":"10","author":"Liu","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0215","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1021\/nn406632u","article-title":"Selective uptake and imaging of aptamer- and antibody-conjugated hollow nanospheres targeted to epidermal growth factor receptors overexpressed in head and neck cancer","volume":"8","author":"Melancon","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0220","first-page":"1083","article-title":"Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells","volume":"9","author":"Li","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cll.2014.06.005","article-title":"Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing","volume":"34","author":"Levy","year":"2014","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11739-008-0201-8","article-title":"Emergency reversal of antithrombotic treatment","volume":"4","author":"Levi","year":"2009","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0235","doi-asserted-by":"crossref","first-page":"g1438","DOI":"10.1136\/bmj.g1438","article-title":"The lack of antidotes for new oral anticoagulants","volume":"348","author":"Wallace","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2015.11.028_bb0240","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/eurheartj\/ehs232","article-title":"A phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial","volume":"34","author":"Povsic","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jconrel.2015.11.028_bb0245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/thno.5409","article-title":"Gold nanorods based platforms for light-mediated theranostics","volume":"3","author":"Zhang","year":"2013","journal-title":"Theranostics"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915302480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915302480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T12:15:49Z","timestamp":1653653749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915302480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":49,"alternative-id":["S0168365915302480"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.028","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gold nanoparticles modified with self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}